BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Prostate
,
Nosology
,
Fenofibrate
,
rs2230926
,
PBX1
,
nitric oxide metabolic process
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
WAL 2014
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
No studies found
Explore Curated Studies Results
Literature
Most Relevant Literature
Phase I clinical trials with WAL 2014, a new muscarinic agonist for the treatment of Alzheimer's dis…
Xanomeline compared to other muscarinic agents on stimulation of phosphoinositide hydrolysis in vivo…
Muscarinic contraction in isolated guinea-pig trachea and antagonism by noradrenaline.
WAL 2014--a muscarinic agonist with preferential neuron-stimulating properties.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Bioequivalence of the New Formulation of WAL 801 CL Dry Syrup Compared to the Conventional Formulati…
WAL 801 CL Dry Syrup in Pediatric Atopic Dermatitis Patients
WAL 801 CL Dry Syrup in Paediatric Atopic Dermatitis Patients
WAL801CL (Epinastine Hydrochloride) Dry Syrup in Paediatric Perennial Allergic Rhinitis
Evaluating Factors That Impact Loss to Follow-up Among Postpartum HIV-infected Women in Mississippi
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ